Outcomes of treatment between streptokinase at the community hospital and primary PCI at tertiary care hospital for STEMI patients, Suratthani, Thailand
Outcomes of treatment between streptokinase at the community hospital and primary PCI at tertiary care hospital for STEMI patients, Suratthani, Thailand
Tuesday, May 21, 2019
Belmont Ballroom 2-3 (The Cosmopolitan of Las Vegas)
Outcomes of treatment between streptokinase at the community hospital and primary PCI at tertiary care hospital for STEMI patients, Suratthani, Thailand ABSTRACT
A retrospective cohort study was conducted at Suratthani hospital in 2016.
Overall 191 STEMI patients. The electrocardiography (EKG) was classified as anterior wall of 103 (53.4%) and inferior wall of 49 (25.4%). Ninety-one (47.6%) patients were treated with SK. The mean ± SD of door to SK time was 200 ± 132 minutes. Compared to SK, primary PCI had more chronic kidney disease (12% vs. 1.1%, P=0.003), higher Killip Class 3 (8% vs. 0%, P=0.007), higher cardiac arrest on admission (9% vs. 0%, P=0.003) but lesser length of hospitalization (median, 3 vs. 2 days , P=0.005). No difference of major bleeding (4% vs. 2.2%, P=0.68) and Intracranial hemorrhage (2.2% vs. 0%, P=0.230) complication. The in-hospital mortality in the primary PCI group was higher (11% vs 1.1%, P=0.005)
Streptokinase is effective treatment in STEMT patient who present at community hospital. In-hospital mortality of STEMI patients treated with primary PCI in tertiary care center was higher compared to SK in the community hospital. However, the primary PCI group was more severe illness at presentation than the SK group.
Background:
Methods
A retrospective cohort study was conducted at Suratthani hospital in 2016.
Results
Overall 191 STEMI patients. The electrocardiography (EKG) was classified as anterior wall of 103 (53.4%) and inferior wall of 49 (25.4%). Ninety-one (47.6%) patients were treated with SK. The mean ± SD of door to SK time was 200 ± 132 minutes. Compared to SK, primary PCI had more chronic kidney disease (12% vs. 1.1%, P=0.003), higher Killip Class 3 (8% vs. 0%, P=0.007), higher cardiac arrest on admission (9% vs. 0%, P=0.003) but lesser length of hospitalization (median, 3 vs. 2 days , P=0.005). No difference of major bleeding (4% vs. 2.2%, P=0.68) and Intracranial hemorrhage (2.2% vs. 0%, P=0.230) complication. The in-hospital mortality in the primary PCI group was higher (11% vs 1.1%, P=0.005)
Conclusions
Streptokinase is effective treatment in STEMT patient who present at community hospital. In-hospital mortality of STEMI patients treated with primary PCI in tertiary care center was higher compared to SK in the community hospital. However, the primary PCI group was more severe illness at presentation than the SK group.